Загрузка...
Immunomodulatory Molecules On Lung Cancer Stem Cells From Lymph Nodes Aspirates
Over the past decade, immune checkpoint inhibitors have revolutionized the treatment of non-small cell lung cancer (NSCLC). Unfortunately, not all patients benefit from PD-(L)1 blockade, yet, the PD-L1 tumor cell expression is the only approved biomarker, and other biomarkers have been investigated....
Сохранить в:
| Опубликовано в: : | Cancers (Basel) |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7226167/ https://ncbi.nlm.nih.gov/pubmed/32244422 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12040838 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|